UTXO Acquisition Inc.
Status: Stalled
U=S+W+R
W=S@11.5
R=S/10
| IPO Proceeds, $M | $50.00M |
|---|---|
| IPO Date | * |
| CEO | Wei Huang |
| Left Lead | Univest Securities |
| IPO Cash in Trust | 101.5% |
| SPAC Tenor | 12+(3*2) |
| IPO Sector |
Healthcare
Digital health/tele-medicine and technology-enabled healthcare services and pharmacy industries |
| IPO Geography | US/Canada |
| Target Company | TBD |
| Deal Announced | TBD |
| Deal Size, $M | TBD |
| Deal Sector | TBD |
| Deal Geography | TBD |
| SEC Filings | www.sec.gov |
| Approval Vote | TBD |
| Amendment Vote | TBD |
UTXO
UTXOU
UTXOW
UTXOR
| Price | |
|---|---|
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on UTXO Acquisition Inc.:
- Structure and cap table
- 7 directors & officers
- 6 filings and events
- 1 underwriters
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Wei Huang | 40 | Chief Executive Officer |
| Yuanyuan Huang | 40 | Chief Financial Officer and Chief Operating Officer |
| Mengyi (Jason) Ye | 32 | Chief Legal Officer, Director, and Chairman of the Board, Class C |
| Jinxiu (Lisa) Liu | 41 | Independent Director, Class B |
| Jiaming Li | 33 | Independent Director, Class B |
| Marta New | 41 | Independent Director, Class A |
| John Reardon | 63 | Independent Director, Class A |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| Univest Securities | BR | 5,000,000 | units |
| 5,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee | 3.50 | % |
Sign in to view more advisor data.
Filings
Sign in to view 6 filings.